Merck KGaA Raises 2021 Forecast on Strong 3Q
03 Novembro 2021 - 03:29PM
Dow Jones News
By Giulia Petroni
Merck KGaA on Wednesday said that it has raised its forecast for
the full year on the back of a strong performance in the third
quarter.
The German pharmaceuticals-and-chemicals company said it expects
net sales of between 19.30 billion euros and 19.85 billion euros
($22.37 billion-$23 billion), from previous guidance of EUR18.80
billion-EUR19.70 billion.
Adjusted earnings before interest, taxes, depreciation and
amortization are seen at around EUR6 billion to EUR6.3 billion,
from EUR5.6 billion-EUR6 billion previously. Adjusted earnings per
share are expected at approximately EUR8.50-EUR9 from
EUR7.80-EUR8.50 previously.
In the third quarter, Merck KGaA said sales were EUR4.97
billion. Adjusted Ebitda came in at EUR1.55 billion, while adjusted
EPS came in at EUR2.24. The main driver was a strong operating
performance from the life-science business, according to the
company.
Merck KGaA is scheduled to release official results on Nov.
11.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
November 03, 2021 14:14 ET (18:14 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024